Key result
This review evaluates the evidence for B-type natriuretic peptide (BNP) testing in the diagnosis of chronic heart failure and discusses the implications of its availability.
Why the study?
Does BNP testing aid diagnosis of heart failure?
Does BNP testing aid diagnosis of heart failure?
This review discusses the evidence and practical implications of using BNP testing for the diagnosis of chronic heart failure, as advocated by UK guidelines.
BNP testing may aid chronic HF diagnosis in primary care; review leaves open optimal thresholds and cost-effectiveness.
Heart failure is common, causes major disability and often shortens life. Two UK guidelines advocate the measurement of plasma concentrations of B-type natriuretic peptide (BNP) in diagnosis of chronic heart failure, either in combination with, or as an alternative to, an ECG.1,2 Here we review the evidence for BNP testing in the diagnosis of chronic heart failure, and discuss the implications in terms of availability of the test.
No takes yet. Share an insight, caveat, or question.
A 2009 study conducted a review in chronic heart failure. B-type natriuretic peptide (BNP) testing vs. ECG was evaluated. This review evaluates the evidence for B-type natriuretic peptide (BNP) testing in the diagnosis of chronic heart failure and discusses the implications of its availability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: